

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | central nervous system myelination (GO:0022010) | 9.49669420 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 9.49669420 |
| 3 | fatty acid elongation (GO:0030497) | 6.21917959 |
| 4 | synaptic vesicle maturation (GO:0016188) | 5.60291746 |
| 5 | long-chain fatty acid biosynthetic process (GO:0042759) | 5.52386077 |
| 6 | myelination (GO:0042552) | 5.38988236 |
| 7 | ensheathment of neurons (GO:0007272) | 5.34082767 |
| 8 | axon ensheathment (GO:0008366) | 5.34082767 |
| 9 | glutamate secretion (GO:0014047) | 5.28879176 |
| 10 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.12606924 |
| 11 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.91662511 |
| 12 | presynaptic membrane organization (GO:0097090) | 4.65952092 |
| 13 | presynaptic membrane assembly (GO:0097105) | 4.63477711 |
| 14 | negative regulation of neurotransmitter transport (GO:0051589) | 4.58803196 |
| 15 | neuron cell-cell adhesion (GO:0007158) | 4.49754079 |
| 16 | L-amino acid import (GO:0043092) | 4.35888337 |
| 17 | negative regulation of neurotransmitter secretion (GO:0046929) | 4.32353112 |
| 18 | neurotransmitter secretion (GO:0007269) | 4.18060162 |
| 19 | regulation of synaptic vesicle transport (GO:1902803) | 3.97207292 |
| 20 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.94758998 |
| 21 | establishment of mitochondrion localization (GO:0051654) | 3.90110066 |
| 22 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.84185281 |
| 23 | cellular potassium ion homeostasis (GO:0030007) | 3.83940807 |
| 24 | negative regulation of protein localization to cell surface (GO:2000009) | 3.81560645 |
| 25 | regulation of collateral sprouting (GO:0048670) | 3.74347943 |
| 26 | neuronal action potential propagation (GO:0019227) | 3.74169068 |
| 27 | eye photoreceptor cell differentiation (GO:0001754) | 3.73219337 |
| 28 | photoreceptor cell differentiation (GO:0046530) | 3.73219337 |
| 29 | membrane depolarization during action potential (GO:0086010) | 3.73106640 |
| 30 | exploration behavior (GO:0035640) | 3.66186865 |
| 31 | oligodendrocyte differentiation (GO:0048709) | 3.65882759 |
| 32 | glycerophospholipid catabolic process (GO:0046475) | 3.63549884 |
| 33 | transmission of nerve impulse (GO:0019226) | 3.60390254 |
| 34 | locomotory exploration behavior (GO:0035641) | 3.60268685 |
| 35 | response to methylmercury (GO:0051597) | 3.58663401 |
| 36 | positive regulation of synapse maturation (GO:0090129) | 3.53503731 |
| 37 | regulation of synapse structural plasticity (GO:0051823) | 3.53492214 |
| 38 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.46766527 |
| 39 | myelin maintenance (GO:0043217) | 3.44873348 |
| 40 | cholesterol biosynthetic process (GO:0006695) | 3.43082158 |
| 41 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 3.41390764 |
| 42 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.40788208 |
| 43 | sodium ion export (GO:0071436) | 3.38750991 |
| 44 | amino acid import (GO:0043090) | 3.35495561 |
| 45 | adult walking behavior (GO:0007628) | 3.34998198 |
| 46 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.33149783 |
| 47 | proline transport (GO:0015824) | 3.33128170 |
| 48 | neurotransmitter transport (GO:0006836) | 3.30954892 |
| 49 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.24432343 |
| 50 | synapse assembly (GO:0007416) | 3.24164747 |
| 51 | nucleobase catabolic process (GO:0046113) | 3.23425004 |
| 52 | response to redox state (GO:0051775) | 3.22386623 |
| 53 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.22080263 |
| 54 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.21336795 |
| 55 | positive regulation of action potential (GO:0045760) | 3.20861208 |
| 56 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.20706046 |
| 57 | import into cell (GO:0098657) | 3.17490022 |
| 58 | apical protein localization (GO:0045176) | 3.17407388 |
| 59 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.17204178 |
| 60 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.17156219 |
| 61 | neurotransmitter uptake (GO:0001504) | 3.16602648 |
| 62 | asymmetric protein localization (GO:0008105) | 3.15607318 |
| 63 | membrane depolarization (GO:0051899) | 3.15370839 |
| 64 | regulation of neurotransmitter levels (GO:0001505) | 3.14620208 |
| 65 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.14458494 |
| 66 | regulation of vesicle fusion (GO:0031338) | 3.12654409 |
| 67 | regulation of postsynaptic membrane potential (GO:0060078) | 3.11685187 |
| 68 | neuron remodeling (GO:0016322) | 3.11019924 |
| 69 | layer formation in cerebral cortex (GO:0021819) | 3.10710486 |
| 70 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.10670323 |
| 71 | positive regulation of membrane potential (GO:0045838) | 3.10557597 |
| 72 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.10117874 |
| 73 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.10050828 |
| 74 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.09551304 |
| 75 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.09419830 |
| 76 | dendrite morphogenesis (GO:0048813) | 3.08968471 |
| 77 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.08791432 |
| 78 | neuron recognition (GO:0008038) | 3.08322984 |
| 79 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.08055174 |
| 80 | substantia nigra development (GO:0021762) | 3.07484241 |
| 81 | limb bud formation (GO:0060174) | 3.07208865 |
| 82 | sterol biosynthetic process (GO:0016126) | 3.06543108 |
| 83 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.05645445 |
| 84 | positive regulation of dendritic spine development (GO:0060999) | 3.04953939 |
| 85 | response to auditory stimulus (GO:0010996) | 3.04215528 |
| 86 | synaptic vesicle endocytosis (GO:0048488) | 3.03153122 |
| 87 | regulation of neurotransmitter secretion (GO:0046928) | 3.02223005 |
| 88 | amyloid precursor protein metabolic process (GO:0042982) | 3.01034026 |
| 89 | isoprenoid biosynthetic process (GO:0008299) | 3.00109103 |
| 90 | cell migration in hindbrain (GO:0021535) | 2.99625412 |
| 91 | regulation of synapse maturation (GO:0090128) | 2.98423891 |
| 92 | astrocyte development (GO:0014002) | 2.98387861 |
| 93 | neuronal action potential (GO:0019228) | 2.97587469 |
| 94 | protein localization to synapse (GO:0035418) | 2.93688441 |
| 95 | GPI anchor biosynthetic process (GO:0006506) | 2.93078472 |
| 96 | urinary tract smooth muscle contraction (GO:0014848) | 2.93004134 |
| 97 | neuromuscular synaptic transmission (GO:0007274) | 2.92015471 |
| 98 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.91467290 |
| 99 | magnesium ion transport (GO:0015693) | 2.91144002 |
| 100 | glutamate receptor signaling pathway (GO:0007215) | 2.89436840 |
| 101 | dendritic spine morphogenesis (GO:0060997) | 2.89141944 |
| 102 | GPI anchor metabolic process (GO:0006505) | 2.87021702 |
| 103 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.86698695 |
| 104 | protein palmitoylation (GO:0018345) | 2.85202904 |
| 105 | synaptic transmission (GO:0007268) | 2.85036875 |
| 106 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.84962376 |
| 107 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.84701324 |
| 108 | serotonin metabolic process (GO:0042428) | 2.84441374 |
| 109 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.84235494 |
| 110 | regulation of dendritic spine development (GO:0060998) | 2.83973444 |
| 111 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.83051241 |
| 112 | regulation of neurotransmitter transport (GO:0051588) | 2.82833970 |
| 113 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.82782497 |
| 114 | regulation of synapse assembly (GO:0051963) | 2.82240110 |
| 115 | neurofilament cytoskeleton organization (GO:0060052) | 2.81377316 |
| 116 | synapse organization (GO:0050808) | 2.79212371 |
| 117 | negative regulation of axonogenesis (GO:0050771) | 2.77444674 |
| 118 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.75784736 |
| 119 | cell communication by electrical coupling (GO:0010644) | 2.75580602 |
| 120 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.75065311 |
| 121 | neuronal ion channel clustering (GO:0045161) | 2.75008444 |
| 122 | regulation of dopamine metabolic process (GO:0042053) | 2.74682546 |
| 123 | regulation of catecholamine metabolic process (GO:0042069) | 2.74682546 |
| 124 | axon development (GO:0061564) | 2.73595798 |
| 125 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.73253217 |
| 126 | long-term memory (GO:0007616) | 2.72086813 |
| 127 | cellular response to epinephrine stimulus (GO:0071872) | 2.70891192 |
| 128 | neuron-neuron synaptic transmission (GO:0007270) | 2.70504817 |
| 129 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.70171530 |
| 130 | C4-dicarboxylate transport (GO:0015740) | 2.69452518 |
| 131 | synaptic transmission, glutamatergic (GO:0035249) | 2.68261197 |
| 132 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.68075320 |
| 133 | synaptic vesicle exocytosis (GO:0016079) | 2.64330581 |
| 134 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.62958961 |
| 135 | nerve growth factor signaling pathway (GO:0038180) | 2.62513753 |
| 136 | response to epinephrine (GO:0071871) | 2.62397412 |
| 137 | axonal fasciculation (GO:0007413) | 2.62176719 |
| 138 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.60735401 |
| 139 | positive regulation of synapse assembly (GO:0051965) | 2.60462987 |
| 140 | startle response (GO:0001964) | 2.60022343 |
| 141 | membrane assembly (GO:0071709) | 2.59959008 |
| 142 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.58877670 |
| 143 | protein neddylation (GO:0045116) | 2.58856310 |
| 144 | postsynaptic membrane organization (GO:0001941) | 2.57672130 |
| 145 | gamma-aminobutyric acid transport (GO:0015812) | 2.55526825 |
| 146 | creatine metabolic process (GO:0006600) | 2.55323963 |
| 147 | mechanosensory behavior (GO:0007638) | 2.53415978 |
| 148 | cerebellar granule cell differentiation (GO:0021707) | 2.51166533 |
| 149 | vocalization behavior (GO:0071625) | 2.50335940 |
| 150 | cranial nerve development (GO:0021545) | 2.50224640 |
| 151 | negative regulation of axon extension (GO:0030517) | 2.48108552 |
| 152 | dopamine biosynthetic process (GO:0042416) | 2.47913043 |
| 153 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.47664097 |
| 154 | adult locomotory behavior (GO:0008344) | 2.47604471 |
| 155 | negative regulation of synaptic transmission (GO:0050805) | 2.45904745 |
| 156 | peripheral nervous system development (GO:0007422) | 2.45651174 |
| 157 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.44112539 |
| 158 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.44112539 |
| 159 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.41268149 |
| 160 | mating behavior (GO:0007617) | 2.40638938 |
| 161 | auditory behavior (GO:0031223) | 2.40381525 |
| 162 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.39484385 |
| 163 | myelination in peripheral nervous system (GO:0022011) | 2.39346342 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.07478789 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.85183119 |
| 3 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.94881566 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.71184268 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.70648974 |
| 6 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.67477492 |
| 7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.59772515 |
| 8 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.40336015 |
| 9 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.29597963 |
| 10 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.24023828 |
| 11 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.23873861 |
| 12 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.22803729 |
| 13 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.22803729 |
| 14 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.19777457 |
| 15 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.17133992 |
| 16 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.16186668 |
| 17 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.13353160 |
| 18 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.13121185 |
| 19 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.08025700 |
| 20 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.05021313 |
| 21 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.02942102 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.99145069 |
| 23 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.98834438 |
| 24 | VDR_22108803_ChIP-Seq_LS180_Human | 1.94837564 |
| 25 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.94126193 |
| 26 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.91152189 |
| 27 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.87192146 |
| 28 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.86230835 |
| 29 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.83917015 |
| 30 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.83878047 |
| 31 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.82305949 |
| 32 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.80727596 |
| 33 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.77628189 |
| 34 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.73064836 |
| 35 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.68219702 |
| 36 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.67214854 |
| 37 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.67039648 |
| 38 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.65137946 |
| 39 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.62911616 |
| 40 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.62851391 |
| 41 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.60956414 |
| 42 | P300_19829295_ChIP-Seq_ESCs_Human | 1.60741187 |
| 43 | FUS_26573619_Chip-Seq_HEK293_Human | 1.60700976 |
| 44 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.57680676 |
| 45 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.57481430 |
| 46 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.56595070 |
| 47 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.54157375 |
| 48 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.40634230 |
| 49 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.40612101 |
| 50 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.39456164 |
| 51 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.36692206 |
| 52 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.35837629 |
| 53 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.33662923 |
| 54 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.31158373 |
| 55 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.31111512 |
| 56 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.30307905 |
| 57 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.27815800 |
| 58 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.26696476 |
| 59 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.22904906 |
| 60 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22066837 |
| 61 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.21854364 |
| 62 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.21447606 |
| 63 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.19213234 |
| 64 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 1.18803228 |
| 65 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.17431394 |
| 66 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.17248831 |
| 67 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.15319233 |
| 68 | * AR_19668381_ChIP-Seq_PC3_Human | 1.14083250 |
| 69 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.12430343 |
| 70 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.12307955 |
| 71 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.10516226 |
| 72 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.10461837 |
| 73 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10247993 |
| 74 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.09912210 |
| 75 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.09084799 |
| 76 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.08842218 |
| 77 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.08453724 |
| 78 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.08168959 |
| 79 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.08020412 |
| 80 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.07259021 |
| 81 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.06553594 |
| 82 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.06506839 |
| 83 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.05551015 |
| 84 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.04812523 |
| 85 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.04389908 |
| 86 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.04082732 |
| 87 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.04027855 |
| 88 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.03846659 |
| 89 | * JUN_21703547_ChIP-Seq_K562_Human | 1.03113763 |
| 90 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.03050312 |
| 91 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.02937129 |
| 92 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.02937129 |
| 93 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.02830217 |
| 94 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.02011820 |
| 95 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.01938511 |
| 96 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.01906633 |
| 97 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.01906633 |
| 98 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.01820523 |
| 99 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.01781040 |
| 100 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.00605780 |
| 101 | AR_25329375_ChIP-Seq_VCAP_Human | 1.00539859 |
| 102 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.00126150 |
| 103 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.00089857 |
| 104 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.99905706 |
| 105 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.99244903 |
| 106 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.99052958 |
| 107 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.99051878 |
| 108 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.98917959 |
| 109 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.98744693 |
| 110 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.98635955 |
| 111 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.97682166 |
| 112 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.96846957 |
| 113 | EWS_26573619_Chip-Seq_HEK293_Human | 0.96714648 |
| 114 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.95836630 |
| 115 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.95369262 |
| 116 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.94736314 |
| 117 | TP53_16413492_ChIP-PET_HCT116_Human | 0.94236388 |
| 118 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93621387 |
| 119 | * KDM2B_26808549_Chip-Seq_REH_Human | 0.92822412 |
| 120 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.92536036 |
| 121 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.92414993 |
| 122 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92414993 |
| 123 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.91761655 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.87302304 |
| 2 | MP0000920_abnormal_myelination | 3.79535537 |
| 3 | MP0004270_analgesia | 3.38656503 |
| 4 | MP0004859_abnormal_synaptic_plasticity | 3.10968013 |
| 5 | MP0005423_abnormal_somatic_nervous | 2.89085544 |
| 6 | MP0002272_abnormal_nervous_system | 2.72412004 |
| 7 | MP0001486_abnormal_startle_reflex | 2.70690138 |
| 8 | MP0005171_absent_coat_pigmentation | 2.69662894 |
| 9 | MP0002064_seizures | 2.64355743 |
| 10 | MP0001529_abnormal_vocalization | 2.60571864 |
| 11 | MP0003635_abnormal_synaptic_transmissio | 2.57703680 |
| 12 | MP0003136_yellow_coat_color | 2.50062284 |
| 13 | MP0009745_abnormal_behavioral_response | 2.45344216 |
| 14 | MP0003950_abnormal_plasma_membrane | 2.45137148 |
| 15 | MP0009046_muscle_twitch | 2.42152897 |
| 16 | MP0001905_abnormal_dopamine_level | 2.38146861 |
| 17 | MP0005409_darkened_coat_color | 2.33791150 |
| 18 | MP0004742_abnormal_vestibular_system | 2.32867063 |
| 19 | MP0003690_abnormal_glial_cell | 2.19308748 |
| 20 | MP0003329_amyloid_beta_deposits | 2.17289407 |
| 21 | MP0002734_abnormal_mechanical_nocicepti | 2.15017947 |
| 22 | MP0005551_abnormal_eye_electrophysiolog | 2.14977036 |
| 23 | MP0004885_abnormal_endolymph | 2.13647584 |
| 24 | MP0000778_abnormal_nervous_system | 2.08257209 |
| 25 | MP0004142_abnormal_muscle_tone | 2.07131925 |
| 26 | MP0002572_abnormal_emotion/affect_behav | 2.04119593 |
| 27 | MP0002063_abnormal_learning/memory/cond | 1.95298533 |
| 28 | MP0003787_abnormal_imprinting | 1.90081263 |
| 29 | MP0001968_abnormal_touch/_nociception | 1.85066994 |
| 30 | MP0000569_abnormal_digit_pigmentation | 1.83060295 |
| 31 | MP0001440_abnormal_grooming_behavior | 1.76927845 |
| 32 | MP0001485_abnormal_pinna_reflex | 1.76791413 |
| 33 | MP0003634_abnormal_glial_cell | 1.72760987 |
| 34 | MP0002229_neurodegeneration | 1.71907842 |
| 35 | MP0001970_abnormal_pain_threshold | 1.66550086 |
| 36 | MP0002067_abnormal_sensory_capabilities | 1.64661783 |
| 37 | MP0003122_maternal_imprinting | 1.60776369 |
| 38 | MP0004381_abnormal_hair_follicle | 1.59471459 |
| 39 | MP0002735_abnormal_chemical_nociception | 1.58584709 |
| 40 | MP0003879_abnormal_hair_cell | 1.54483318 |
| 41 | MP0002882_abnormal_neuron_morphology | 1.48982538 |
| 42 | MP0002736_abnormal_nociception_after | 1.47623182 |
| 43 | MP0008569_lethality_at_weaning | 1.47007805 |
| 44 | MP0002733_abnormal_thermal_nociception | 1.45246398 |
| 45 | MP0006072_abnormal_retinal_apoptosis | 1.44615376 |
| 46 | MP0005410_abnormal_fertilization | 1.43440198 |
| 47 | MP0000955_abnormal_spinal_cord | 1.41783454 |
| 48 | MP0002822_catalepsy | 1.41706684 |
| 49 | MP0001501_abnormal_sleep_pattern | 1.40495385 |
| 50 | MP0004924_abnormal_behavior | 1.40401999 |
| 51 | MP0005386_behavior/neurological_phenoty | 1.40401999 |
| 52 | MP0009780_abnormal_chondrocyte_physiolo | 1.39394547 |
| 53 | MP0003632_abnormal_nervous_system | 1.39193281 |
| 54 | MP0001963_abnormal_hearing_physiology | 1.32507018 |
| 55 | MP0002752_abnormal_somatic_nervous | 1.29760241 |
| 56 | MP0002066_abnormal_motor_capabilities/c | 1.29496537 |
| 57 | MP0003631_nervous_system_phenotype | 1.29064107 |
| 58 | MP0005253_abnormal_eye_physiology | 1.28599730 |
| 59 | MP0006276_abnormal_autonomic_nervous | 1.26643577 |
| 60 | MP0001188_hyperpigmentation | 1.26432728 |
| 61 | MP0002184_abnormal_innervation | 1.25239616 |
| 62 | MP0000372_irregular_coat_pigmentation | 1.24770474 |
| 63 | MP0003633_abnormal_nervous_system | 1.23631880 |
| 64 | MP0005645_abnormal_hypothalamus_physiol | 1.22351478 |
| 65 | MP0004043_abnormal_pH_regulation | 1.18336496 |
| 66 | MP0002557_abnormal_social/conspecific_i | 1.17430075 |
| 67 | MP0005503_abnormal_tendon_morphology | 1.16453200 |
| 68 | MP0005187_abnormal_penis_morphology | 1.13744316 |
| 69 | MP0003938_abnormal_ear_development | 1.09036971 |
| 70 | MP0005195_abnormal_posterior_eye | 1.08749284 |
| 71 | MP0000462_abnormal_digestive_system | 1.07184797 |
| 72 | MP0004145_abnormal_muscle_electrophysio | 1.04402345 |
| 73 | MP0001986_abnormal_taste_sensitivity | 1.04236371 |
| 74 | MP0001502_abnormal_circadian_rhythm | 1.02969606 |
| 75 | MP0000026_abnormal_inner_ear | 1.02736616 |
| 76 | MP0005646_abnormal_pituitary_gland | 0.99893635 |
| 77 | MP0008877_abnormal_DNA_methylation | 0.98403321 |
| 78 | MP0002638_abnormal_pupillary_reflex | 0.97925358 |
| 79 | MP0010678_abnormal_skin_adnexa | 0.95910637 |
| 80 | MP0001984_abnormal_olfaction | 0.94410776 |
| 81 | MP0000604_amyloidosis | 0.92753320 |
| 82 | MP0002152_abnormal_brain_morphology | 0.92591394 |
| 83 | MP0003121_genomic_imprinting | 0.92582740 |
| 84 | MP0002102_abnormal_ear_morphology | 0.91482834 |
| 85 | MP0000383_abnormal_hair_follicle | 0.90842030 |
| 86 | MP0000631_abnormal_neuroendocrine_gland | 0.90469136 |
| 87 | MP0004147_increased_porphyrin_level | 0.87181663 |
| 88 | MP0000566_synostosis | 0.87059962 |
| 89 | MP0001661_extended_life_span | 0.86643504 |
| 90 | MP0002909_abnormal_adrenal_gland | 0.86629391 |
| 91 | MP0003283_abnormal_digestive_organ | 0.86434676 |
| 92 | MP0008260_abnormal_autophagy | 0.85992759 |
| 93 | MP0002090_abnormal_vision | 0.85615013 |
| 94 | MP0001299_abnormal_eye_distance/ | 0.85218929 |
| 95 | MP0004085_abnormal_heartbeat | 0.81647987 |
| 96 | MP0001346_abnormal_lacrimal_gland | 0.80401021 |
| 97 | MP0000751_myopathy | 0.80122546 |
| 98 | MP0004134_abnormal_chest_morphology | 0.79185323 |
| 99 | MP0002069_abnormal_eating/drinking_beha | 0.78543571 |
| 100 | MP0002751_abnormal_autonomic_nervous | 0.78086739 |
| 101 | MP0004811_abnormal_neuron_physiology | 0.77264402 |
| 102 | MP0000534_abnormal_ureter_morphology | 0.75445488 |
| 103 | MP0004215_abnormal_myocardial_fiber | 0.74984710 |
| 104 | MP0001177_atelectasis | 0.74082825 |
| 105 | MP0005451_abnormal_body_composition | 0.69505712 |
| 106 | MP0010386_abnormal_urinary_bladder | 0.68904569 |
| 107 | MP0004133_heterotaxia | 0.68453708 |
| 108 | MP0003861_abnormal_nervous_system | 0.66277604 |
| 109 | MP0000049_abnormal_middle_ear | 0.64581350 |
| 110 | MP0001664_abnormal_digestion | 0.63790692 |
| 111 | MP0004130_abnormal_muscle_cell | 0.62373816 |
| 112 | MP0003011_delayed_dark_adaptation | 0.61421319 |
| 113 | MP0001943_abnormal_respiration | 0.60959831 |
| 114 | MP0000647_abnormal_sebaceous_gland | 0.60895028 |
| 115 | MP0003137_abnormal_impulse_conducting | 0.60620374 |
| 116 | MP0000762_abnormal_tongue_morphology | 0.60531633 |
| 117 | MP0000747_muscle_weakness | 0.60083003 |
| 118 | MP0000013_abnormal_adipose_tissue | 0.59787947 |
| 119 | MP0002234_abnormal_pharynx_morphology | 0.59115928 |
| 120 | MP0005623_abnormal_meninges_morphology | 0.58605851 |
| 121 | MP0005408_hypopigmentation | 0.58247925 |
| 122 | MP0010770_preweaning_lethality | 0.57815741 |
| 123 | MP0002082_postnatal_lethality | 0.57815741 |
| 124 | MP0003045_fibrosis | 0.57628075 |
| 125 | MP0002938_white_spotting | 0.56895127 |
| 126 | MP0010769_abnormal_survival | 0.56814524 |
| 127 | MP0003937_abnormal_limbs/digits/tail_de | 0.55097378 |
| 128 | MP0005595_abnormal_vascular_smooth | 0.54673697 |
| 129 | MP0006292_abnormal_olfactory_placode | 0.54189543 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 5.59638754 |
| 2 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 5.59638754 |
| 3 | Neurofibrillary tangles (HP:0002185) | 5.35590311 |
| 4 | Parakeratosis (HP:0001036) | 4.40607474 |
| 5 | Abnormality of the corticospinal tract (HP:0002492) | 4.33467465 |
| 6 | Peripheral hypomyelination (HP:0007182) | 4.31242476 |
| 7 | Limb dystonia (HP:0002451) | 4.17155112 |
| 8 | Focal motor seizures (HP:0011153) | 3.90309384 |
| 9 | Cerebral inclusion bodies (HP:0100314) | 3.84348267 |
| 10 | Sensory axonal neuropathy (HP:0003390) | 3.61682363 |
| 11 | Supranuclear gaze palsy (HP:0000605) | 3.58010360 |
| 12 | Myokymia (HP:0002411) | 3.54889067 |
| 13 | Drooling (HP:0002307) | 3.39725374 |
| 14 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.34157412 |
| 15 | Retinal dysplasia (HP:0007973) | 3.23640845 |
| 16 | Epileptiform EEG discharges (HP:0011182) | 3.22085474 |
| 17 | Abnormal eating behavior (HP:0100738) | 3.14309182 |
| 18 | Excessive salivation (HP:0003781) | 3.10732783 |
| 19 | Spastic gait (HP:0002064) | 3.06284295 |
| 20 | Absent speech (HP:0001344) | 3.06165018 |
| 21 | Termporal pattern (HP:0011008) | 3.00960638 |
| 22 | Insidious onset (HP:0003587) | 3.00960638 |
| 23 | Dysmetria (HP:0001310) | 2.99694590 |
| 24 | EEG with generalized epileptiform discharges (HP:0011198) | 2.98894657 |
| 25 | Torticollis (HP:0000473) | 2.92332377 |
| 26 | Onion bulb formation (HP:0003383) | 2.90531311 |
| 27 | Epileptic encephalopathy (HP:0200134) | 2.87609861 |
| 28 | Hypsarrhythmia (HP:0002521) | 2.81358585 |
| 29 | Genetic anticipation (HP:0003743) | 2.79584383 |
| 30 | Scanning speech (HP:0002168) | 2.77012397 |
| 31 | Polyphagia (HP:0002591) | 2.74473624 |
| 32 | Urinary urgency (HP:0000012) | 2.72893189 |
| 33 | Alacrima (HP:0000522) | 2.72352395 |
| 34 | Focal seizures (HP:0007359) | 2.70622843 |
| 35 | Inability to walk (HP:0002540) | 2.63306885 |
| 36 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.56328834 |
| 37 | Atonic seizures (HP:0010819) | 2.54187582 |
| 38 | Mutism (HP:0002300) | 2.51036579 |
| 39 | Status epilepticus (HP:0002133) | 2.47053974 |
| 40 | Intention tremor (HP:0002080) | 2.46279857 |
| 41 | Amblyopia (HP:0000646) | 2.45197060 |
| 42 | Ankle clonus (HP:0011448) | 2.43790185 |
| 43 | Thickened helices (HP:0000391) | 2.43468710 |
| 44 | Amyotrophic lateral sclerosis (HP:0007354) | 2.42279802 |
| 45 | Abnormal auditory evoked potentials (HP:0006958) | 2.42134170 |
| 46 | Cerebral hypomyelination (HP:0006808) | 2.40991511 |
| 47 | Absent septum pellucidum (HP:0001331) | 2.40988601 |
| 48 | Hemiplegia (HP:0002301) | 2.40859208 |
| 49 | Clumsiness (HP:0002312) | 2.40253164 |
| 50 | Anteriorly placed anus (HP:0001545) | 2.40019609 |
| 51 | Abnormality of glycolysis (HP:0004366) | 2.39550417 |
| 52 | Increased serum pyruvate (HP:0003542) | 2.39550417 |
| 53 | Poor eye contact (HP:0000817) | 2.39335183 |
| 54 | Renal Fanconi syndrome (HP:0001994) | 2.38022400 |
| 55 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.37894954 |
| 56 | Leukodystrophy (HP:0002415) | 2.36875409 |
| 57 | Slow saccadic eye movements (HP:0000514) | 2.35749697 |
| 58 | Postural instability (HP:0002172) | 2.35477349 |
| 59 | Papilledema (HP:0001085) | 2.34151244 |
| 60 | Broad-based gait (HP:0002136) | 2.33940732 |
| 61 | Vaginal atresia (HP:0000148) | 2.33748068 |
| 62 | Progressive cerebellar ataxia (HP:0002073) | 2.33371784 |
| 63 | Abnormality of the lower motor neuron (HP:0002366) | 2.32621765 |
| 64 | Akinesia (HP:0002304) | 2.32241941 |
| 65 | White forelock (HP:0002211) | 2.29002438 |
| 66 | Genital tract atresia (HP:0001827) | 2.27023378 |
| 67 | Increased circulating renin level (HP:0000848) | 2.26408059 |
| 68 | Patchy hypopigmentation of hair (HP:0011365) | 2.26210447 |
| 69 | Spastic tetraplegia (HP:0002510) | 2.25955640 |
| 70 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.25058536 |
| 71 | Cupped ear (HP:0000378) | 2.23460624 |
| 72 | Dialeptic seizures (HP:0011146) | 2.22729156 |
| 73 | Split foot (HP:0001839) | 2.20470190 |
| 74 | Focal dystonia (HP:0004373) | 2.20078221 |
| 75 | Hyperventilation (HP:0002883) | 2.19904159 |
| 76 | Decreased lacrimation (HP:0000633) | 2.18405271 |
| 77 | Protruding tongue (HP:0010808) | 2.17066692 |
| 78 | Hypoplastic pelvis (HP:0008839) | 2.16981430 |
| 79 | Acute necrotizing encephalopathy (HP:0006965) | 2.16822387 |
| 80 | Hypoventilation (HP:0002791) | 2.16791549 |
| 81 | Hemiparesis (HP:0001269) | 2.15736331 |
| 82 | Metabolic alkalosis (HP:0200114) | 2.15212709 |
| 83 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.13025041 |
| 84 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.12811649 |
| 85 | Aplasia of the phalanges of the hand (HP:0009802) | 2.12811649 |
| 86 | Aplasia involving bones of the extremities (HP:0009825) | 2.12811649 |
| 87 | Abnormality of the septum pellucidum (HP:0007375) | 2.11799220 |
| 88 | Humeroradial synostosis (HP:0003041) | 2.10366453 |
| 89 | Synostosis involving the elbow (HP:0003938) | 2.10366453 |
| 90 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.10194715 |
| 91 | Absent/shortened dynein arms (HP:0200106) | 2.10194715 |
| 92 | Pheochromocytoma (HP:0002666) | 2.09383531 |
| 93 | Gait imbalance (HP:0002141) | 2.05023107 |
| 94 | Craniofacial dystonia (HP:0012179) | 2.04146028 |
| 95 | Clonus (HP:0002169) | 2.04110387 |
| 96 | Impaired smooth pursuit (HP:0007772) | 2.04070626 |
| 97 | Congenital sensorineural hearing impairment (HP:0008527) | 2.03638488 |
| 98 | Cerebral hemorrhage (HP:0001342) | 2.02425490 |
| 99 | Hypomagnesemia (HP:0002917) | 2.01804038 |
| 100 | Blue irides (HP:0000635) | 1.99368785 |
| 101 | Neuroendocrine neoplasm (HP:0100634) | 1.99236848 |
| 102 | Autoamputation (HP:0001218) | 1.98540707 |
| 103 | Gaze-evoked nystagmus (HP:0000640) | 1.97420216 |
| 104 | Hypoplasia of the iris (HP:0007676) | 1.97331962 |
| 105 | Progressive inability to walk (HP:0002505) | 1.97106845 |
| 106 | Medial flaring of the eyebrow (HP:0010747) | 1.96434097 |
| 107 | Fetal akinesia sequence (HP:0001989) | 1.95971952 |
| 108 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.94689393 |
| 109 | Action tremor (HP:0002345) | 1.94543305 |
| 110 | Morphological abnormality of the inner ear (HP:0011390) | 1.93905323 |
| 111 | Abnormality of salivation (HP:0100755) | 1.92400153 |
| 112 | Anxiety (HP:0000739) | 1.92258755 |
| 113 | Lower limb muscle weakness (HP:0007340) | 1.91841940 |
| 114 | Impaired social interactions (HP:0000735) | 1.91650509 |
| 115 | Abnormal social behavior (HP:0012433) | 1.91650509 |
| 116 | Febrile seizures (HP:0002373) | 1.91519926 |
| 117 | Sleep apnea (HP:0010535) | 1.91284555 |
| 118 | Ulnar claw (HP:0001178) | 1.90609048 |
| 119 | Truncal ataxia (HP:0002078) | 1.89461299 |
| 120 | Megalencephaly (HP:0001355) | 1.88501859 |
| 121 | Dysdiadochokinesis (HP:0002075) | 1.87550924 |
| 122 | Widely spaced teeth (HP:0000687) | 1.87191048 |
| 123 | Absence seizures (HP:0002121) | 1.85988761 |
| 124 | Visual hallucinations (HP:0002367) | 1.85980016 |
| 125 | Increased hepatocellular lipid droplets (HP:0006565) | 1.85442266 |
| 126 | Progressive macrocephaly (HP:0004481) | 1.84946705 |
| 127 | Congenital stationary night blindness (HP:0007642) | 1.84826327 |
| 128 | Hypoplasia of the corpus callosum (HP:0002079) | 1.84525710 |
| 129 | Generalized myoclonic seizures (HP:0002123) | 1.83995384 |
| 130 | Mitochondrial inheritance (HP:0001427) | 1.80733087 |
| 131 | Abolished electroretinogram (ERG) (HP:0000550) | 1.80591125 |
| 132 | Nephrogenic diabetes insipidus (HP:0009806) | 1.80290840 |
| 133 | Agitation (HP:0000713) | 1.80073173 |
| 134 | Hypothermia (HP:0002045) | 1.79988212 |
| 135 | Partial agenesis of the corpus callosum (HP:0001338) | 1.79658923 |
| 136 | Optic disc pallor (HP:0000543) | 1.79635006 |
| 137 | Congenital primary aphakia (HP:0007707) | 1.79443983 |
| 138 | Methylmalonic acidemia (HP:0002912) | 1.78472412 |
| 139 | Generalized tonic-clonic seizures (HP:0002069) | 1.78353593 |
| 140 | Diplopia (HP:0000651) | 1.78298595 |
| 141 | Abnormality of binocular vision (HP:0011514) | 1.78298595 |
| 142 | Specific learning disability (HP:0001328) | 1.78091341 |
| 143 | CNS hypomyelination (HP:0003429) | 1.77997197 |
| 144 | Septo-optic dysplasia (HP:0100842) | 1.77329303 |
| 145 | 3-Methylglutaconic aciduria (HP:0003535) | 1.77180250 |
| 146 | Prolonged QT interval (HP:0001657) | 1.76982062 |
| 147 | Lissencephaly (HP:0001339) | 1.76800960 |
| 148 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.76657190 |
| 149 | Esotropia (HP:0000565) | 1.73837144 |
| 150 | Delusions (HP:0000746) | 1.73457358 |
| 151 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.73181604 |
| 152 | Incomplete penetrance (HP:0003829) | 1.71899918 |
| 153 | Depression (HP:0000716) | 1.70355985 |
| 154 | Failure to thrive in infancy (HP:0001531) | 1.67908552 |
| 155 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.67716215 |
| 156 | Exotropia (HP:0000577) | 1.67358291 |
| 157 | Spastic tetraparesis (HP:0001285) | 1.66071138 |
| 158 | Pachygyria (HP:0001302) | 1.64245319 |
| 159 | Bradykinesia (HP:0002067) | 1.64094289 |
| 160 | Primary atrial arrhythmia (HP:0001692) | 1.62187936 |
| 161 | Bradycardia (HP:0001662) | 1.61524621 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 5.15438807 |
| 2 | OXSR1 | 3.81514827 |
| 3 | TNIK | 3.03243978 |
| 4 | CASK | 2.49037784 |
| 5 | EPHB1 | 2.46514075 |
| 6 | PNCK | 2.38441084 |
| 7 | MAPKAPK5 | 2.36297301 |
| 8 | PKN1 | 2.24729407 |
| 9 | EPHA4 | 2.20364277 |
| 10 | CDK19 | 2.19588652 |
| 11 | BCR | 2.13833209 |
| 12 | PBK | 2.10196829 |
| 13 | DAPK2 | 2.08552586 |
| 14 | WNK4 | 2.01835303 |
| 15 | AKT3 | 1.95351307 |
| 16 | SIK2 | 1.89561996 |
| 17 | FRK | 1.81609362 |
| 18 | NTRK3 | 1.77141082 |
| 19 | CAMKK2 | 1.76915022 |
| 20 | MARK1 | 1.72208099 |
| 21 | PINK1 | 1.70103344 |
| 22 | NTRK1 | 1.66435994 |
| 23 | UHMK1 | 1.66109080 |
| 24 | FGFR2 | 1.60941058 |
| 25 | CAMK2B | 1.60287862 |
| 26 | WNK1 | 1.59928468 |
| 27 | MET | 1.50200921 |
| 28 | MST4 | 1.44199981 |
| 29 | CAMKK1 | 1.43455736 |
| 30 | NEK6 | 1.41240563 |
| 31 | CSNK1G3 | 1.38231733 |
| 32 | FGR | 1.36504999 |
| 33 | CAMK2D | 1.30537452 |
| 34 | MAP2K4 | 1.28249642 |
| 35 | CSNK1A1L | 1.25704499 |
| 36 | BMPR1B | 1.25530749 |
| 37 | PAK6 | 1.25035843 |
| 38 | NTRK2 | 1.21001705 |
| 39 | CSNK1G2 | 1.19055945 |
| 40 | ROCK2 | 1.17663191 |
| 41 | CLK1 | 1.17621258 |
| 42 | MUSK | 1.16796150 |
| 43 | CAMK2A | 1.12977353 |
| 44 | GRK7 | 1.11096176 |
| 45 | TESK2 | 1.09182414 |
| 46 | LIMK1 | 1.08629316 |
| 47 | SGK223 | 1.08542370 |
| 48 | SGK494 | 1.08542370 |
| 49 | SGK2 | 1.07287308 |
| 50 | PRPF4B | 1.06606317 |
| 51 | CDK5 | 1.05761007 |
| 52 | MAPK13 | 1.04547944 |
| 53 | CSNK1G1 | 1.03046665 |
| 54 | PRKD3 | 0.98613830 |
| 55 | MARK2 | 0.98197119 |
| 56 | FES | 0.95774979 |
| 57 | STK38 | 0.94246164 |
| 58 | MAPK15 | 0.94126499 |
| 59 | MAP3K4 | 0.92115982 |
| 60 | CAMK2G | 0.91736782 |
| 61 | ARAF | 0.90283708 |
| 62 | MAP2K7 | 0.89103431 |
| 63 | LATS2 | 0.87770538 |
| 64 | ICK | 0.87647165 |
| 65 | PRKCE | 0.85667881 |
| 66 | PRKCQ | 0.84823657 |
| 67 | DYRK2 | 0.82873326 |
| 68 | PHKG2 | 0.82052717 |
| 69 | PHKG1 | 0.82052717 |
| 70 | MAP3K9 | 0.79985057 |
| 71 | GRK5 | 0.78096511 |
| 72 | MYLK | 0.77760516 |
| 73 | EPHA3 | 0.77270062 |
| 74 | CDK14 | 0.76982584 |
| 75 | PAK3 | 0.75927307 |
| 76 | MAP3K13 | 0.75884318 |
| 77 | KSR1 | 0.75002126 |
| 78 | MAP4K2 | 0.74575772 |
| 79 | CAMK4 | 0.72577319 |
| 80 | CDK15 | 0.72049484 |
| 81 | IRAK2 | 0.71843447 |
| 82 | ADRBK2 | 0.71289109 |
| 83 | TYRO3 | 0.71026363 |
| 84 | GRK1 | 0.69837405 |
| 85 | CDK18 | 0.68903356 |
| 86 | MAP3K12 | 0.68399519 |
| 87 | ERBB3 | 0.67103071 |
| 88 | DYRK1A | 0.65029709 |
| 89 | CDK11A | 0.64936163 |
| 90 | BMPR2 | 0.63108931 |
| 91 | STK16 | 0.59899195 |
| 92 | CDK3 | 0.59188265 |
| 93 | PRKCZ | 0.59177869 |
| 94 | ADRBK1 | 0.58371153 |
| 95 | SGK3 | 0.58253073 |
| 96 | NME1 | 0.58097243 |
| 97 | MINK1 | 0.57628476 |
| 98 | MAPK12 | 0.57620661 |
| 99 | FYN | 0.56924123 |
| 100 | PLK2 | 0.55764530 |
| 101 | PRKG1 | 0.54678151 |
| 102 | STK11 | 0.51426602 |
| 103 | PTK2B | 0.50664141 |
| 104 | DDR2 | 0.49984860 |
| 105 | RPS6KA3 | 0.49978059 |
| 106 | RPS6KA5 | 0.49924903 |
| 107 | CAMK1G | 0.49694621 |
| 108 | DAPK1 | 0.49219329 |
| 109 | INSRR | 0.48272934 |
| 110 | EPHB2 | 0.47674127 |
| 111 | ROCK1 | 0.47658717 |
| 112 | PDPK1 | 0.47221104 |
| 113 | PRKD1 | 0.47137346 |
| 114 | PRKCG | 0.45409400 |
| 115 | RIPK4 | 0.45042290 |
| 116 | RIPK1 | 0.44756289 |
| 117 | CAMK1 | 0.43093011 |
| 118 | CCNB1 | 0.43031540 |
| 119 | CSNK1D | 0.42978783 |
| 120 | MKNK1 | 0.42593138 |
| 121 | BLK | 0.42026536 |
| 122 | MAP3K6 | 0.41863389 |
| 123 | WNK3 | 0.41700080 |
| 124 | CSNK1A1 | 0.40469767 |
| 125 | PRKACA | 0.40429625 |
| 126 | TLK1 | 0.40164969 |
| 127 | ERBB4 | 0.39908366 |
| 128 | PRKACB | 0.39725307 |
| 129 | TIE1 | 0.39341797 |
| 130 | PDGFRA | 0.38992352 |
| 131 | SGK1 | 0.38886831 |
| 132 | MAPK10 | 0.38256382 |
| 133 | TRIM28 | 0.37990590 |
| 134 | KSR2 | 0.37568854 |
| 135 | PIK3CA | 0.36431788 |
| 136 | YES1 | 0.30847807 |
| 137 | PRKCH | 0.30814785 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 4.18410172 |
| 2 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.24149288 |
| 3 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.08155552 |
| 4 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.64131841 |
| 5 | Nicotine addiction_Homo sapiens_hsa05033 | 2.59219804 |
| 6 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.51561847 |
| 7 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.49436252 |
| 8 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.36089322 |
| 9 | GABAergic synapse_Homo sapiens_hsa04727 | 2.23699946 |
| 10 | Phototransduction_Homo sapiens_hsa04744 | 2.18092416 |
| 11 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.16292665 |
| 12 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.15743901 |
| 13 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.99608249 |
| 14 | Morphine addiction_Homo sapiens_hsa05032 | 1.97983620 |
| 15 | Axon guidance_Homo sapiens_hsa04360 | 1.70854820 |
| 16 | Circadian entrainment_Homo sapiens_hsa04713 | 1.68171222 |
| 17 | Alzheimers disease_Homo sapiens_hsa05010 | 1.67758752 |
| 18 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.67418442 |
| 19 | Parkinsons disease_Homo sapiens_hsa05012 | 1.65525021 |
| 20 | Protein export_Homo sapiens_hsa03060 | 1.59921081 |
| 21 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.55801749 |
| 22 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.55663014 |
| 23 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.54971599 |
| 24 | Long-term depression_Homo sapiens_hsa04730 | 1.54274752 |
| 25 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.43575544 |
| 26 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.41619307 |
| 27 | Salivary secretion_Homo sapiens_hsa04970 | 1.41205596 |
| 28 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.35304884 |
| 29 | Taste transduction_Homo sapiens_hsa04742 | 1.34720618 |
| 30 | Cocaine addiction_Homo sapiens_hsa05030 | 1.33427575 |
| 31 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.29475242 |
| 32 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.28023310 |
| 33 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.27727477 |
| 34 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.26928618 |
| 35 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.26862292 |
| 36 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.12871587 |
| 37 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.10711823 |
| 38 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.10505884 |
| 39 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.09463817 |
| 40 | Olfactory transduction_Homo sapiens_hsa04740 | 1.07779079 |
| 41 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.07768131 |
| 42 | Long-term potentiation_Homo sapiens_hsa04720 | 1.07014435 |
| 43 | Renin secretion_Homo sapiens_hsa04924 | 1.03340155 |
| 44 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.98627870 |
| 45 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.98067976 |
| 46 | Huntingtons disease_Homo sapiens_hsa05016 | 0.95986887 |
| 47 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.94439659 |
| 48 | Insulin secretion_Homo sapiens_hsa04911 | 0.93146870 |
| 49 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.92135883 |
| 50 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.92033642 |
| 51 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.90572471 |
| 52 | Circadian rhythm_Homo sapiens_hsa04710 | 0.89935712 |
| 53 | Histidine metabolism_Homo sapiens_hsa00340 | 0.89410410 |
| 54 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.87386554 |
| 55 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.87183578 |
| 56 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.84723856 |
| 57 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.82689418 |
| 58 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.81039140 |
| 59 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.80551116 |
| 60 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.79480613 |
| 61 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.79265413 |
| 62 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.78611407 |
| 63 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.78029898 |
| 64 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.77206184 |
| 65 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.77135456 |
| 66 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.77009843 |
| 67 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.76879481 |
| 68 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.75768429 |
| 69 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.75696014 |
| 70 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.74958440 |
| 71 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.73979896 |
| 72 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.73835344 |
| 73 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.67418412 |
| 74 | Glioma_Homo sapiens_hsa05214 | 0.67166186 |
| 75 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.65766829 |
| 76 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.65658584 |
| 77 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.64641182 |
| 78 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.63920600 |
| 79 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.61790295 |
| 80 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.61247373 |
| 81 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.61176763 |
| 82 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.60586239 |
| 83 | Gap junction_Homo sapiens_hsa04540 | 0.60444143 |
| 84 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.57813402 |
| 85 | Bile secretion_Homo sapiens_hsa04976 | 0.57714227 |
| 86 | Mineral absorption_Homo sapiens_hsa04978 | 0.57676210 |
| 87 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.57555937 |
| 88 | Melanogenesis_Homo sapiens_hsa04916 | 0.56595719 |
| 89 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.54906410 |
| 90 | Tight junction_Homo sapiens_hsa04530 | 0.54019501 |
| 91 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.53596990 |
| 92 | Alcoholism_Homo sapiens_hsa05034 | 0.53078743 |
| 93 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.52589627 |
| 94 | Endocytosis_Homo sapiens_hsa04144 | 0.48898172 |
| 95 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.48469481 |
| 96 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.47783777 |
| 97 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.46274434 |
| 98 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.45068305 |
| 99 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.44727833 |
| 100 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.44708299 |
| 101 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.44357640 |
| 102 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.43794494 |
| 103 | ABC transporters_Homo sapiens_hsa02010 | 0.43147350 |
| 104 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.42776960 |
| 105 | Melanoma_Homo sapiens_hsa05218 | 0.41893476 |
| 106 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.40039246 |
| 107 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.39800077 |
| 108 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.38026439 |
| 109 | Phagosome_Homo sapiens_hsa04145 | 0.34007737 |
| 110 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.33871475 |
| 111 | Focal adhesion_Homo sapiens_hsa04510 | 0.32836427 |
| 112 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.30717985 |
| 113 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.30458344 |
| 114 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.30151024 |
| 115 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.29394292 |
| 116 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.28857371 |
| 117 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.27769687 |
| 118 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.26994942 |
| 119 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.26943402 |
| 120 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.26735769 |
| 121 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.26658260 |
| 122 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.25961420 |
| 123 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.24804539 |
| 124 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.24308311 |

